Visium Asset Management
View Older Stories View More Recent Stories
-
Form 8-K VISIUM TECHNOLOGIES, For: Nov 22
-
Visium Technologies Awarded Subcontract for $20 Million
-
Form 10-Q VISIUM TECHNOLOGIES, For: Sep 30
-
Form NT 10-Q VISIUM TECHNOLOGIES, For: Sep 30
-
Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials.
-
Wasabi Technologies Partners with Leading Security Providers to Deliver Next-Generation Cloud Storage to Australia and New Zealand Surveillance Industry
-
OWKIN Integrates 10x Genomics (TXG) Spatial Omics and Single-Cell Technologies to the MOSAIC Study
-
OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study
-
10x Genomics Reports Third Quarter 2023 Financial Results
-
New API Extends the Utility of ATX Visium SBB Security Adapter in Enterprise Environments
-
Form 8-K VISIUM TECHNOLOGIES, For: Oct 19
-
Form 10-K VISIUM TECHNOLOGIES, For: Jun 30
-
Form NT 10-K VISIUM TECHNOLOGIES, For: Jun 30
-
ATX to Showcase Broadband, Media Distribution and Energy Storage Expertise at SCTE Cable-Tec Expo 2023
-
Visium Technologies, Inc. Issues Letter to Shareholders
-
Visium Technologies Receives Letter of Intent from Cybastion Institute of Technology for Major Projects in Côte d'Ivoire
-
Form 8-K VISIUM TECHNOLOGIES, For: Sep 12
-
Visium Technologies Retires Variable Rate Convertible Note
-
Visium Technologies Retires Variable Rate Convertible Note
-
CDE Lightband Plugs in ATX Visium SBB to Enhance Services to Commercial Customers
-
Study Enabled by 10x Genomics Single Cell and Spatial Technologies Explains Why Immunotherapy is More Effective for Certain Brain Tumors Than Others
-
Form 8-K VISIUM TECHNOLOGIES, For: Aug 14
-
10x Genomics Reports Second Quarter 2023 Financial Results
-
Director Appointment
-
Visium Technologies Signs $2.5M Revolving Line of Credit Agreement to Finance Pending Contracts
-
ATX Joins NCTC Connected Supplier Partnership Program
-
Visium Technologies, Applied Integrated Technologies, and Forbes Consulting Announce Signing of MoU to Partner for Delivery of Cybersecurity Technology
-
Sequana Medical announces results of Special General Meeting of Shareholders
-
ATX Showcases Expanded Edge Compute Capabilities of Visium MD Platform at HITEC 2023
-
Visium Technologies Announces MOU with Cybastion Institute of Technology
-
Visium Technologies Announces Strategic Partnership with Cybersecurity Assurance Services Caribbean, Ltd to Provide Comprehensive Cybersecurity Solutions in Trinidad and Tobago
-
Form 8-K VISIUM TECHNOLOGIES, For: Jun 01
-
10x Genomics (TXG) Launches Visium CytAssist Gene and Protein Expression Assay
-
10x Genomics Launches Visium CytAssist Gene and Protein Expression Assay
-
Form 10-Q VISIUM TECHNOLOGIES, For: Mar 31
-
Visium Technologies Pays Off Outstanding Toxic Convertible Note
-
10x Genomics Reports First Quarter 2023 Financial Results
-
Visium Technologies, Inc. Issues Letter to Shareholders
-
Visium Technologies and Republic of Malawi Sign Memorandum of Understanding for Strategic Partnership to Deploy TruContext Advanced Predictive Analytics
-
Visium Technologies Announces Partnership with Bahamas Mobile Services, Ltd.
-
JenaValve Appoints Ken MacLeod, Ph.D. to Board of Directors
-
JenaValve Appoints Ken MacLeod, Ph.D. to Board of Directors
-
Visium Technologies Announces Partnership with We Source It 4 U, Ltd
-
Visium Technologies To Attend Africa Fintech Summit
-
Form 8-K VISIUM TECHNOLOGIES, For: Mar 16
-
Presenting on the Emerging Growth Conference on March 22 Register Now
-
Visium Technologies to Present at the Emerging Growth Conference on March 22, 2023
-
Form 8-K VISIUM TECHNOLOGIES, For: Feb 28
-
Presenting on the Emerging Growth Conference on March 8 Register Now
-
Form 10-Q/A VISIUM TECHNOLOGIES, For: Dec 31

